① AiFe ZhiYao completed approximately 100 million yuan in angel investment. It independently developed the PharmAgents system, and its ADHD pipeline has advanced to the pre-clinical candidate compound confirmation stage. ② Companies such as InSilicon Intelligence and Jiatai Technology have reached cooperation or are advancing clinical trials in the field of AI-based drug development. The global AI-based drug development market is expected to exceed 46 billion US dollars by 2035.

① AiFeng Pharma completes a pre-seed round financing of approximately 1 billion yuan, has independently developed the PharmAgents system, and its ADHD pipeline has advanced to the stage of confirming preclinical candidate compounds. ② Companies such as Insilico Medicine and Jiate Technology have reached collaborations or progressed into clinical development in the AI-driven pharmaceutical field; the global AI pharmaceutical market is expected to exceed 46 billion US dollars by 2035.

# The development of AI-based pharmaceutical innovation is accelerating, with many companies entering the field ## Aifuizhiyao completed approximately 100 million yuan in angel investment, advancing its ADHD pipeline to the pre-clinical candidate compound confirmation stage Aifuizhiyao (Beijing) Technology Co., Ltd. recently completed angel investment, with a funding amount of approximately 100 million yuan. Xianghe Capital led the investment, with Xinglian Capital and other institutions participating as backers. Aifuizhiyao was established in July 2026, with its headquarters located in Haidian District, Beijing. It is a pharmaceutical startup specializing in AI Native technology, independently developing the PharmAgents intelligent agent system and advancing drug pipeline development. The team at Aifuizhiyao includes Gao Bowen, a computer science doctoral student from the Institute of Intelligent Industries at Tsinghua University, as CEO. Lan Yanyan, the chief scientist, is the deputy dean and chief researcher of the same institute, having 20 years of experience in artificial intelligence and natural language processing, with research published in leading journals such as *Nature* and *Science*. Zhang Yaqin, the chief scientific advisor, is a chair professor of intelligent science at Tsinghua University, the founding dean of the Institute of Intelligent Industries, and an academician from multiple countries. Other core members include doctors, assistant researchers from the School of Life Sciences at Tsinghua University, and well-known B…